Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Texas
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Hanna, Ehab MD | $44.37 | 149 |
| Efeovbokhan, Ughanmwan NP | $44.37 | 114 |
| Nguyen, Todd M.D. | $44.37 | 68 |
| Q Med Laboratory, Llc | $44.37 | 26 |
| Grewal, Ranjit M.D. | $44.37 | 17 |
Texas Pricing in Context
In Texas, CPT code 86328 (Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative) carries an average Medicare payment of $44.37 — 0% above the national benchmark of $44.34. 79 providers across the state submitted claims for this procedure in 2023, performing 829 total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $114.89, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Texas lands near $102.05, with self-pay cash prices typically around $64.87. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost in Texas?
The average Medicare payment for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Texas is $44.37, which is 0% above the national average of $44.34. Providers in TX typically bill $114.89 for this procedure.
What does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost with insurance in Texas?
With commercial insurance in Texas, Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs an estimated $102.05. Without insurance, the estimated cash price is $64.87. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Texas?
79 providers in Texas billed Medicare for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in 2023, performing 829 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cheaper in Texas than the national average?
No — Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs 0% above the national average in Texas. The state average Medicare payment is $44.37 compared to $44.34 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.